Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Coughlan

Showing results (101-110 of 158) with videos related to

Pageof 16
Sort By:
Kidney International|May 14, 2010
Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathySally A Penfold, Melinda T Coughlan, Sheila K Patel, et al.
Journal of the Neurological Sciences|July 18, 2024
von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapyD R Smith, S T Lim, S J X Murphy, et al.
Redox Biology|March 24, 2025
Proximal tubular deletion of superoxide dismutase-2 reveals disparate effects on kidney function in diabetesInez A Trambas, Lilliana Bowen, Vicki Thallas-Bonke, et al.
Journal of the American Society of Nephrology : JASN|January 23, 2009
RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetesMelinda T Coughlan, David R Thorburn, Sally A Penfold, et al.
Diabetologia|July 16, 2010
Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptorK C Sourris, A L Morley, A Koitka, et al.
Journal of the Neurological Sciences|March 22, 2017
Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypesW O Tobin, J A Kinsella, G F Kavanagh, et al.
Clinical Science (London, England : 1979)|February 3, 2016
Mapping time-course mitochondrial adaptations in the kidney in experimental diabetesMelinda T Coughlan, Tuong-Vi Nguyen, Sally A Penfold, et al.
Cardiovascular Drugs and Therapy|February 17, 2020
Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic HeartMitchel Tate, Gavin C Higgins, Miles J De Blasio, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 14, 2026
APOE-mediated sex differences in microvascular pathology and AD-associated proteinopathies in the medial temporal lobeFrancesco Bax, Jan Oltmer, Corinne A Auger, et al.
Cardiovascular Drugs and Therapy|October 27, 2019
The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic HeartMitchel Tate, Gavin C Higgins, Miles J De Blasio, et al.
Pageof 16

Showing results (101-110 of 158) with videos related to

Sort By:
Pageof 16
Kidney International|May 14, 2010
Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathySally A Penfold, Melinda T Coughlan, Sheila K Patel, et al.
Journal of the Neurological Sciences|July 18, 2024
von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapyD R Smith, S T Lim, S J X Murphy, et al.
Redox Biology|March 24, 2025
Proximal tubular deletion of superoxide dismutase-2 reveals disparate effects on kidney function in diabetesInez A Trambas, Lilliana Bowen, Vicki Thallas-Bonke, et al.
Journal of the American Society of Nephrology : JASN|January 23, 2009
RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetesMelinda T Coughlan, David R Thorburn, Sally A Penfold, et al.
Diabetologia|July 16, 2010
Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptorK C Sourris, A L Morley, A Koitka, et al.
Journal of the Neurological Sciences|March 22, 2017
Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypesW O Tobin, J A Kinsella, G F Kavanagh, et al.
Clinical Science (London, England : 1979)|February 3, 2016
Mapping time-course mitochondrial adaptations in the kidney in experimental diabetesMelinda T Coughlan, Tuong-Vi Nguyen, Sally A Penfold, et al.
Cardiovascular Drugs and Therapy|February 17, 2020
Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic HeartMitchel Tate, Gavin C Higgins, Miles J De Blasio, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 14, 2026
APOE-mediated sex differences in microvascular pathology and AD-associated proteinopathies in the medial temporal lobeFrancesco Bax, Jan Oltmer, Corinne A Auger, et al.
Cardiovascular Drugs and Therapy|October 27, 2019
The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic HeartMitchel Tate, Gavin C Higgins, Miles J De Blasio, et al.
Pageof 16